Project Grant HT94252410027
- This $300,378 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at the University of Arizona to identify a male-specific mechanism of nociceptor sensitization that promotes migraine in active-duty service members and veterans. The research aims to develop new treatments, diagnostic tools, and clinical practice guidelines to improve the health and care of military personnel and their families. As an...
- The University of Arizona, doing business as the Arizona Board of Regents, has been awarded a $1,696,170 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from August 1, 2025 to July 31, 2029, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research initiatives under this grant will span multiple...
- The University of Arizona was awarded a $1,791,407 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) on March 1, 2025. The grant will fund research targeting drug resistance in the bone microenvironment using a novel PIM-PROTAC, with an ultimate completion date of February 29, 2028. This research initiative aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
- The University of Arizona was awarded a $2.456 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to identify the role of the rostral ventromedial medulla in mediating postoperative thermal and mechanical hypersensitivity reduction after green light exposure. As the prime grantee, the University of Arizona will conduct the scientific...
- This $1,195,956 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and translation of a virtual reality-based military operational neuropsychological assessment tool. The funding will enable the University of Arizona, as the prime awardee, to create and validate a model for this innovative virtual reality assessment system. The anticipated completion date for this 3-year effort is September 29,...
- The University of Arizona, through the Arizona Board of Regents, was awarded a $3,004,651 Project Grant from the Defense Health Agency to develop a treatment for neuropsychological and memory impairments following moderate to severe traumatic brain injury. This grant, awarded under the Military Medical Research and Development (CFDA 12.420) program, funds a research project aimed at advancing scientific understanding and improving patient care for service members and veterans affected by...
- The University of Arizona, through its Arizona Board of Regents, was awarded a $687,884 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING PROLACTIN FOR PREVENTION OF FEMALE-SELECTIVE NOCICEPTOR SENSITIZATION FOR TREATMENT OF FEMALE-PREDOMINANT PAIN SYNDROMES". This 4-year research project, with a start date of September 1, 2023, aims to transform healthcare for Service Members and the...
- The Department of Defense's Defense Health Agency awarded a $2,728,777 Project Grant to the Rector & Visitors of the University of Virginia (UVA) under the Military Medical Research and Development (CFDA 12.420) program. The grant is for a research project titled "NEUROACTIVE STEROID BIOSYNTHESIS AND DYNAMIC GABAA RECEPTOR RECONFIGURATION IN POSTPARTUM DEPRESSION" with a performance period from May 1, 2025 to April 30, 2029. The project aims to conduct advanced biomedical...
- The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
- This $2,504,526 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to develop novel GABA transaminase inhibitors that can cross the blood-brain barrier and treat hyperglycemia, hyperinsulinemia, and insulin resistance. The primary awardee is the University of Arizona, which will collaborate with the University of Florida on this 4-year effort. The University of Florida will receive a $732,014...
This $306,971 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research into the "Neurovascular Mechanisms of Depression and Implications in Cardiovascular Health" at the University of Arizona. The 2-year grant, which commenced on April 1, 2024, funds basic and applied research activities by the University to investigate the relationships between neurological, vascular, and psychological factors underlying depression and their impact on cardiovascular health. Key research areas may include theoretical and computational modeling, laboratory experimentation, field data collection, and development of new treatments or interventions. As a major public research university and Hispanic Serving Institution, the University of Arizona will leverage its broad scientific and technical capabilities across disciplines like biomedical sciences, neuroscience, and cardiovascular health to advance the program's research objectives and deliver findings to support the mission of the Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $307.0k | 11/20/23 |